Asthma

Both RespiClick inhalers were observed to improve lung function in patients with asthma.

Officials with AstraZeneca recently announced that the FDA has expanded the indication of its 80/4.5 mcg budesonide and formoterol fumarate dihydrate inhalation aerosol (Symbicort), approving the drug for the treatment of asthma in patients aged 6 to 12 years.

Children born to mothers who took heartburn medication were more likely to visit the physician for asthma symptoms.

Individuals enrolled in high-deductible health plans face thousands in out of pocket costs.

Individuals with chronic diseases and high-deductible health insurance spend more than 10% on out-of-pocket costs.

A combination of oxaprozin and salbutamol would provide patients with an easier treatment regimen.

Due to the high cost of biologic drugs for severe asthma, it is vital for the most efficient drug to be used for each patient.

Healthcare support staff and community and social services workers led all occupations in rates of asthma occurrence.

An initiative that lowered copays for prescription drugs also lowered hospitalizations by 40%

Patients who discontinued long-term treatment with omalizumab more likely to experience severe asthma exacerbation.

Top news of the day from across the health care landscape.

Benralizumab reduced the annual rate of asthma exacerbations by up to 51%.

Cromolyn sodium associated with reduced liver fibrosis.

Anti-inflammatory cromolyn sodium shows potential to reduce liver fibrosis

Prescribed dosage of aminophylline in children with acute severe asthma may not improve the condition.

Pharmacists should recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma because the devices can help improve hand-breath coordination while reducing side effects of inhaled medication.

Healthcare resource use and costs related to eosinophil level in patients with asthma.

Once-daily tiotropium added to ICS maintenance therapy found safe and effective in moderate symptomatic asthma.

This Continuing Education activity is supported by an educational grant from Philips Respironics, Inc.

Novartis has introduced a new point-of-care diagnostic tool that allows for in-office diagnosis of uncontrolled allergic asthma mediated by immunoglobulin E (IgE) in conjunction with other clinical findings.

System may improve diagnosis of immunogolbulin E-related conditions.

Oral supplements may boost current asthma treatments to significantly reduce the risk for asthma attacks.

New evidence suggests that oral supplements taken with asthma treatments significantly reduce the risk for asthma attack.

Patient persistence with AirFluSal Forspiro was twice the rate of Seretide Diskus.

Preschool-aged children who suffer a viral-triggered asthma attack have an increased chance of treatment failure.